Literature DB >> 9495606

Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.

C M Mazure1, M B Bowers.   

Abstract

Elevated pretreatment plasma free homovanillic acid (HVA) predicted acute response to neuroleptic treatment in patients with manic psychosis. These findings suggest that plasma HVA may be a useful predictor of a successful short-term response in manic as well as schizophrenic psychoses, and that elevated pre-synaptic dopaminergic release may play a role in more than one group of psychotic disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9495606     DOI: 10.1016/s0165-0327(97)00159-6

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  The Phenomenology of Delusions in a Patient with Disorders of Sex Development.

Authors:  Işıl Göğcegöz Gül; Gökben Hizli Sayar; Eylem Özten; Gül Eryilmaz
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

2.  Interaction of DRD2TaqI, COMT, and ALDH2 genes associated with bipolar II disorder comorbid with anxiety disorders in Han Chinese in Taiwan.

Authors:  Ming-Chuan Hu; Sheng-Yu Lee; Tzu-Yun Wang; Yun-Hsuan Chang; Shiou-Lan Chen; Shih-Heng Chen; Chun-Hsien Chu; Chen-Lin Wang; I Hui Lee; Po See Chen; Yen Kuang Yang; Ru-Band Lu
Journal:  Metab Brain Dis       Date:  2014-11-29       Impact factor: 3.584

3.  GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.

Authors:  Aurora Arrúe; Ricardo Dávila; Mercedes Zumárraga; Nieves Basterreche; Miguel A González-Torres; Biotza Goienetxea; Maria I Zamalloa; Juan B Anguiano; José Guimón
Journal:  Neurochem Res       Date:  2009-08-22       Impact factor: 3.996

4.  Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report.

Authors:  Itaru Miura; Soichi Kono; Sachie Oshima; Keiko Kanno-Nozaki; Hirobumi Mashiko; Shin-Ichi Niwa; Hirooki Yabe
Journal:  Neuropsychiatr Dis Treat       Date:  2014-03-25       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.